These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31947743)

  • 1. Disabling the Protease DDI2 Attenuates the Transcriptional Activity of NRF1 and Potentiates Proteasome Inhibitor Cytotoxicity.
    Northrop A; Vangala JR; Feygin A; Radhakrishnan SK
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31947743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The aspartyl protease DDI2 activates Nrf1 to compensate for proteasome dysfunction.
    Koizumi S; Irie T; Hirayama S; Sakurai Y; Yashiroda H; Naguro I; Ichijo H; Hamazaki J; Murata S
    Elife; 2016 Aug; 5():. PubMed ID: 27528193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p97-dependent retrotranslocation and proteolytic processing govern formation of active Nrf1 upon proteasome inhibition.
    Radhakrishnan SK; den Besten W; Deshaies RJ
    Elife; 2014; 3():e01856. PubMed ID: 24448410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The aspartyl protease DDI2 drives adaptation to proteasome inhibition in multiple myeloma.
    Op M; Ribeiro ST; Chavarria C; De Gassart A; Zaffalon L; Martinon F
    Cell Death Dis; 2022 May; 13(5):475. PubMed ID: 35589686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf1 can be processed and activated in a proteasome-independent manner.
    Vangala JR; Sotzny F; Krüger E; Deshaies RJ; Radhakrishnan SK
    Curr Biol; 2016 Sep; 26(18):R834-R835. PubMed ID: 27676297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival.
    Chen T; Ho M; Briere J; Moscvin M; Czarnecki PG; Anderson KC; Blackwell TK; Bianchi G
    Blood Adv; 2022 Jan; 6(2):429-440. PubMed ID: 34649278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nelfinavir inhibits human DDI2 and potentiates cytotoxicity of proteasome inhibitors.
    Gu Y; Wang X; Wang Y; Wang Y; Li J; Yu FX
    Cell Signal; 2020 Nov; 75():109775. PubMed ID: 32916277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDI2 Is a Ubiquitin-Directed Endoprotease Responsible for Cleavage of Transcription Factor NRF1.
    Dirac-Svejstrup AB; Walker J; Faull P; Encheva V; Akimov V; Puglia M; Perkins D; Kümper S; Hunjan SS; Blagoev B; Snijders AP; Powell DJ; Svejstrup JQ
    Mol Cell; 2020 Jul; 79(2):332-341.e7. PubMed ID: 32521225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ER-Resident Transcription Factor Nrf1 Regulates Proteasome Expression and Beyond.
    Hamazaki J; Murata S
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBE4A catalyzes NRF1 ubiquitination and facilitates DDI2-mediated NRF1 cleavage.
    Hu X; Zou R; Zhang Z; Ji J; Li J; Huo XY; Liu D; Ge MX; Cui MK; Wu MZ; Li ZP; Wang Q; Zhang X; Zhang ZR
    Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194937. PubMed ID: 37084817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome-mediated processing of Nrf1 is essential for coordinate induction of all proteasome subunits and p97.
    Sha Z; Goldberg AL
    Curr Biol; 2014 Jul; 24(14):1573-1583. PubMed ID: 24998528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCF11/Nrf1-Mediated Induction of Proteasome Expression Prevents Cytotoxicity by Rotenone.
    Sotzny F; Schormann E; Kühlewindt I; Koch A; Brehm A; Goldbach-Mansky R; Gilling KE; Krüger E
    Antioxid Redox Signal; 2016 Dec; 25(16):870-885. PubMed ID: 27345029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of calpain-1 stabilizes TCF11/Nrf1 but does not affect its activation in response to proteasome inhibition.
    Nowak K; Taubert RM; Haberecht S; Venz S; Krüger E
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30177525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nelfinavir Inhibits the TCF11/Nrf1-Mediated Proteasome Recovery Pathway in Multiple Myeloma.
    Fassmannová D; Sedlák F; Sedláček J; Špička I; Grantz Šašková K
    Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32344880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of the 26S proteasome by Nrf1.
    Koizumi S; Hamazaki J; Murata S
    Proc Jpn Acad Ser B Phys Biol Sci; 2018; 94(8):325-336. PubMed ID: 30305478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of NRF1, a master transcription factor of proteasome genes: implications for cancer and neurodegeneration.
    Northrop A; Byers HA; Radhakrishnan SK
    Mol Biol Cell; 2020 Sep; 31(20):2158-2163. PubMed ID: 32924844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reply to Vangala et al.: Complete inhibition of the proteasome reduces new proteasome production by causing Nrf1 aggregation.
    Sha Z; Goldberg AL
    Curr Biol; 2016 Sep; 26(18):R836-R837. PubMed ID: 27676298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early recovery of proteasome activity in cells pulse-treated with proteasome inhibitors is independent of DDI2.
    Ibtisam I; Kisselev AF
    Elife; 2024 Apr; 12():. PubMed ID: 38619391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation and Functions of the ER-Associated Nrf1 Transcription Factor.
    Ruvkun G; Lehrbach N
    Cold Spring Harb Perspect Biol; 2023 Jan; 15(1):. PubMed ID: 35940907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ER-trafficking triggers NRF1 ubiquitination to promote its proteolytic activation.
    Chavarria C; Zaffalon L; Ribeiro ST; Op M; Quadroni M; Iatrou MS; Chapuis C; Martinon F
    iScience; 2023 Oct; 26(10):107777. PubMed ID: 37720101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.